Reaching Others University at Buffalo - The State University of New York
Skip to Content

Kapoor (John) Hall

Kapoor

Overview

Facility
KAPOOR
Number
0011
Function
Academic
Gross Square Feet
163,822
Construction Cost
$55,000,000
Completed
August, 2012
Architect
Duane Lyman & Associaties

Occupants

Function

The approximately 160,000 square foot facility, renamed from Acheson Hall in honor of alumnus John Kapoor 72, is home to The School of Pharmacy and Pharmaceutical Sciences. The existing building was stripped down to its original concrete structural frame and will incorporate many green design features such as maximizing natural daylight (75 percent of all space in the building will receive natural light). The building will achieve a LEED silver rating and will provide a state-of-the-art Pharmaceutical Care and Teaching Center and establish a better link between the Academic Health Center and the School of Pharmacy and Pharmaceutical Sciences.

Namesake

Kapoor

President of EJ Financial Enterprises, Inc., and a skilled entrepreneur who has transformed numerous businesses into profitable corporations, John N. Kapoor, Ph.D. '72, for nearly a decade has been the most generous donor to the UB pharmacy school, which is ranked in the top two of Northeast U.S. pharmacy schools and in the top 25 nationwide. Born in Amristar, India, Kapoor earned an undergraduate degree in pharmacy from Bombay University, and sought to attend graduate school in the United States. UB offered him a graduate fellowship, allowing him to pursue a doctorate in medicinal chemistry. Throughout his career, Kapoor has demonstrated keen marketing insight. As president and CEO of LyphoMed, he rejuvenated the hospital products company into a more than $100-million-a-year business, which he then sold to Fujisawa Pharmaceuticals. He went on to serve in leadership positions at several U.S. pharmaceutical companies over the next 30 years, including Option Care, Inc., a provider of home health-care services; Akorn, Inc., a manufacturer and marketer of generic ophthalmic products; and Introgen Therapeutics, Inc., a gene therapy company.

Historical research and photographs provided by University Archives.